Whoop announced this morning that it has partnered up with G42 HealthCare. This makes the wearable tracker the first of its kind in the world to be used in a Phase-3 COVID-19 vaccine trial.
The company’s new initiative Whoop4Humanity ensures that volunteers who now join the clinical trials at ADNEC in Abu Dhabi and the Al Qarain Center in Sharjah, including those coming in for the second dose, can further enhance their participation in the trials by using the new wearable devices. These devices enable them to check their daily heart rate, respiratory rate, heart rate variability, sleep performance, and more.
G42 Healthcare believes that WHOOP can be a powerful tool to boost the comprehensive volunteer healthcare management program by helping thousands of vaccine volunteers to self-monitor their well-being while measuring their fitness, sleep, and recovery levels during the trials.
WHOOP provides valuable insights and actionable feedback around specific markers, thus encouraging better decision making for volunteers’ health and contributing to the trials’ overall success.
Related reading
- WHOOP positioning as a clinical tool for Heart Failure management
- Whoop working towards features to monitor IBD Flareups
- Biostrap Wristband to power investigation of long term cardiovascular impacts of COVID-19
- 5 Best air purifiers for your home that help keep your air clean
Whoop’s Phase-3 COVID 19 vaccine trial details
The trials began in Abu Dhabi on 16th July and are being managed by G4 Healthcare in partnership with the Department of Health – Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP), and Abu Dhabi Health Services Company (SEHA).
They are being conducted following the international guidelines stipulated by the World Health Organization (WHO) and the United States Food & Drug Administration (USFDA).
Whoop has been focussed around potential new use cases that focus on using respiratory rate to track COVID related symptoms. 
These are amazing wins for Will Ahmed and his Whoop team.
This news comes on the heels of a major partnership with NFL that was announced this week.
The NFLPA did considerable research on respiratory rate and health monitoring before doubling down on choosing Whoop to help players return safely.
